p53 inhibits vascular endothelial growth factor expression in solid tumor

Journal of Surgical Research

Volumn 174, Issue 2, 2012, Pages 291-297

  Yoshioka, Yasuhiko ^a   Shimizu, Shigeomi ^b   Ito, Toshinori ^a   Taniguchi, Masahiko ^a   Nomura, Masaya ^a   Nishida, Toshirou ^a   Sawa, Yoshiki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Tokyo Medical and Dental University ^*  (Japan)

Author keywords

HIF 1; p53; VEGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1BETA; PROTEIN P53; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; MUTATION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; TUMOR GROWTH; VASCULARIZATION;

AGED; ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CELL LINE, TUMOR; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MALE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; POINT MUTATION; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84859524245     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.12.028     Document Type: Article

References (16)

1. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353.
2. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005;438:967.
3. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat Med 2003;6:677.
4. Kapitsinou PP, Haase VH. The VHL tumor suppressor and HIF: Insights from genetic studies in mice. Cell Death Differ 2008;4:650.
5. 2 tension. Proc Natl Acad Sci U S A 1995;92:5510.
6. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1a in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 1998;394:485.
7. An WG, Kanekal M, Simon MC, et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1a. Nature 1998;392:405.
8. Chen D, Li M, Luo J, Gu W. Direct interactions between HIF-α and Mdm2 modulate p53 function. J Biol Chem 2003;278:13595.
9. Yu JL, Rak JW, Coomber BL, et al. Effect of p53 status on tumor response to antiangiogenic therapy. Science 2002;295:1526.
10. Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1a. Genes Dev 2000;14:34.
11. Blagosklonny MV, An WG, Romanova LY, et al. p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem 1998;273:11995.
12. Liu J, Shibata T, Qu R, Ogura M, Hiraoka M. Influences of the p53 status on hypoxia-induced gene expression. J Radiat Res (Tokyo) 2004;45:333.
13. Agani F, Kirsch DG, Friedman SL, et al. p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene. Cancer Res 1997;57:4474.
14. Wenger RH, Camenisch G, Desbaillets I, et al. Up-regulation of hypoxia-inducible factor-1alpha is not sufficient for hypoxic/anoxic p53 induction. Cancer Res 1998;58:5678.
15. Hongyo T, Kurooka M, Taniguchi E, et al. Frequent p53 mutations at dipyrimidine sites in patients with pyothoraxassociated lymphoma. Cancer Res 1998;58:1105.
16. Friedlander P, Legros Y, Soussi T, et al. Regulation of mutant p53 temperature-sensitive DNA binding. J Biol Chem 1996;271:25468.